CN114569677A - Traditional Chinese medicine formula for treating depression - Google Patents
Traditional Chinese medicine formula for treating depression Download PDFInfo
- Publication number
- CN114569677A CN114569677A CN202210269117.4A CN202210269117A CN114569677A CN 114569677 A CN114569677 A CN 114569677A CN 202210269117 A CN202210269117 A CN 202210269117A CN 114569677 A CN114569677 A CN 114569677A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine formula
- treating depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 244000197580 Poria cocos Species 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 12
- 235000011477 liquorice Nutrition 0.000 claims abstract description 12
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 10
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 241000208340 Araliaceae Species 0.000 claims description 13
- 241000209020 Cornus Species 0.000 claims description 12
- 244000046146 Pueraria lobata Species 0.000 claims description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- 241000305491 Gastrodia elata Species 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 7
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 7
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 7
- 241001061264 Astragalus Species 0.000 claims description 2
- 210000004233 talus Anatomy 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 abstract description 3
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- GDLIGKIOYRNHDA-UHFFFAOYSA-N Clomipramine Chemical compound C1CC2=CC=C(Cl)C=C2N(CCCN(C)C)C2=CC=CC=C21 GDLIGKIOYRNHDA-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014357 Electric shock Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010019070 Hallucination, auditory Diseases 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229960004606 clomipramine Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229960005426 doxepin Drugs 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229960001785 mirtazapine Drugs 0.000 description 1
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 description 1
- 229960005017 olanzapine Drugs 0.000 description 1
- -1 paloxetine Chemical compound 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000079 pharmacotherapeutic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229960002073 sertraline Drugs 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229960004688 venlafaxine Drugs 0.000 description 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 description 1
- 206010047470 viral myocarditis Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine formula for treating depression, which comprises the following components in parts by weight: 18-22 parts of poria cocos, 14-16 parts of radix puerariae, 8-10 parts of rhizoma gastrodiae, 10-12 parts of dogwood, 10-12 parts of angelica sinensis, 3-4 parts of ginseng, 8-10 parts of rhizoma polygonati, 8-10 parts of liquorice and 10-12 parts of astragalus membranaceus. Is suitable for patients with depression of different sexes and age groups, and is mainly used for treating mild and moderate depression and climacteric syndrome.
Description
Technical Field
The invention relates to the field of disease treatment, in particular to a traditional Chinese medicine formula for treating depression.
Background
Depression is a common mental disorder, and belongs to the category of depression in traditional Chinese medicine. The depression seriously troubles the life and work of patients and brings a heavy burden to families. Current treatments are mainly psychotherapeutic, pharmacotherapeutic and electroconvulsive (tic) therapy. The psychological treatment method is only suitable for mild cases, moderate and severe cases need drug treatment, and for severe cases, the method of electric shock treatment is used. Western medicines are mostly used as antidepressant medicines and have strong dependence.
The following were used: 1. tricyclic drugs: such as doxepin, amitriptyline, clomipramine and the like, although the medicaments have low price, the side effects are large, mainly dry mouth, accelerated heart rate and the like, and the life risk is caused by overdose of the medicaments.
2. 5-hydroxytryptamine reuptake blocking class: such as fluoxetine, paloxetine, sertraline and the like, can cause adverse gastrointestinal reactions such as constipation, nausea, vomiting and the like.
Norepinephrine drugs: mirtazapine, venlafaxine, etc. can produce side effects such as hepatotoxicity, sexual dysfunction, obesity, etc. when taken in excess.
Therefore, a traditional Chinese medicine formula for treating depression is provided.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine formula for treating depression.
In order to achieve the purpose, the invention is realized by the following technical scheme:
the invention provides a traditional Chinese medicine formula for treating depression, which comprises the following components in parts by weight: 18-22 parts of poria cocos, 14-16 parts of kudzu root, 8-10 parts of gastrodia elata, 10-12 parts of dogwood, 10-12 parts of angelica sinensis, 3-4 parts of ginseng, 8-10 parts of rhizoma polygonati, 8-10 parts of liquorice and 10-12 parts of astragalus membranaceus.
Preferably, the traditional Chinese medicine formula for treating depression comprises the following components in parts by weight: 18 parts of tuckahoe, 14 parts of kudzu root, 8 parts of gastrodia elata, 10 parts of dogwood, 10 parts of angelica, 3 parts of ginseng, 8 parts of rhizoma polygonati, 8 parts of liquorice and 10 parts of astragalus membranaceus.
Preferably, the traditional Chinese medicine formula for treating depression comprises the following components in parts by weight: 20 parts of tuckahoe, 15 parts of kudzu root, 9 parts of gastrodia elata, 11 parts of dogwood, 11 parts of angelica, 3 parts of ginseng, 9 parts of rhizoma polygonati, 9 parts of liquorice and 11 parts of astragalus membranaceus.
Preferably, the traditional Chinese medicine formula for treating depression comprises the following components in parts by weight: 22 parts of tuckahoe, 16 parts of kudzu root, 10 parts of gastrodia elata, 12 parts of dogwood, 12 parts of angelica, 4 parts of ginseng, 10 parts of rhizoma polygonati, 10 parts of liquorice and 12 parts of astragalus membranaceus.
Preferably, the traditional Chinese medicine needs 100 parts by weight of water, and is stewed in boiling water.
Preferably, the boiling water is stewed in a standard atmospheric pressure device for 3 hours.
Kudzu root: sweet and pungent in flavor and cool in nature; entering lung and stomach meridians; has effects in expelling pathogenic factors from muscles, relieving fever, promoting eruption, promoting salivation, quenching thirst, invigorating yang, and relieving diarrhea; can be used for treating fever due to exterior syndrome, pain of neck and back, measles without adequate eruption, fever thirst, yin deficiency with thirst, heat diarrhea, dysentery, and diarrhea due to spleen deficiency.
Gastrodia elata: mild in nature and bland in taste, entering liver meridian. Has effects of suppressing hyperactive liver, calming endogenous wind, and relieving spasm, and can be used for treating headache, giddiness, limbs anesthesia, infantile convulsion, epilepsia, convulsion, and tetanus. The rhizoma Gastrodiae extract and water decoction have tranquilizing, analgesic, and anticonvulsive effects; the rhizoma Gastrodiae polysaccharide has effects of enhancing nonspecific immunity and cellular immunity of experimental animal organism and resisting inflammation. In addition, it has the functions of delaying senility, inhibiting platelet aggregation, protecting cardiac muscle cell, etc.
Dogwood fruit: slightly warm in nature, sour and astringent in taste; entering liver and kidney meridians; has effects in tonifying liver and kidney, and inducing astringency to arrest spontaneous perspiration; can be used for treating vertigo, tinnitus, soreness of waist and knees, sexual impotence, spermatorrhea, enuresis, frequent micturition, metrorrhagia, leukorrhagia, sweating, internal heat, and diabetes. Pharmacological research shows that the medicine has the functions of enhancing the immune system, resisting inflammation, resisting hemorrhagic shock, reducing blood sugar, inhibiting platelet aggregation, improving the cardiac function and the hemodynamics, resisting bacteria, promoting urination, etc.
Chinese angelica root: warm in nature, sweet and pungent in flavor; it enters liver meridian, heart meridian and spleen meridian; has effects in replenishing blood, promoting blood circulation, regulating menstruation, relieving pain, loosening bowel, and relieving constipation; it is used to treat sallow complexion due to blood deficiency, vertigo, palpitation, menoxenia, amenorrhea, dysmenorrhea, abdominal pain due to deficiency cold, constipation due to intestinal dryness, rheumatic arthralgia, traumatic injury, carbuncle, cellulitis, and pyocutaneous disease.
Ginseng: warm in nature, sweet and slightly bitter in taste; enter heart meridian, lung meridian, spleen meridian, kidney meridian; has effects of invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, and tranquilizing; can be used for treating asthenia, desire for loss of life, short breath, dyspnea, spontaneous perspiration, cold limbs, listlessness, anorexia, emesis, diarrhea, asthma due to qi deficiency, chronic cough, body fluid deficiency, thirst, diabetes, insomnia, dreaminess, palpitation, amnesia, sexual impotence, frequent micturition, and deficiency of qi, blood, and body fluid. Ginseng radix has effects of bidirectional regulating central nervous system, promoting intelligence, relieving pain, relieving fever, resisting convulsion and reducing muscle strength. Has effects in tonifying heart, relieving ischemia, dilating blood vessel, and lowering blood pressure; has the functions of protecting and stimulating hematopoiesis to the blood system, and resisting blood coagulation and thrombus; has corticotropin-like and sex hormone-like effects on endocrine system.
Rhizoma polygonati: mild in nature and sweet in taste; it enters lung, spleen and kidney meridians; has effects in invigorating qi, nourishing yin, invigorating spleen, moistening lung, and invigorating kidney; it is used to treat weakness of spleen and stomach, tiredness, asthenia, xerostomia, dry cough due to lung deficiency, insufficiency of essence and blood, and diabetes due to internal heat.
Licorice root: mild in nature and sweet in taste; the heart meridian, the stomach meridian, the spleen meridian and the lung meridian; has effects in invigorating spleen, invigorating qi, relieving cough, eliminating phlegm, relieving spasm, relieving pain, and regulating drug properties; treating weakness of spleen and stomach, deficiency of middle-warmer energy, cough, asthma, carbuncle, sore, abdominal spasm, pain, and relieving drug toxicity. Unprocessed for clearing heat, stir-baked for tonifying middle energizer.
Astragalus root: mild in nature and sweet in taste; spleen and lung meridians entered; has effects in invigorating qi, consolidating superficial resistance, promoting urination, expelling toxin, expelling pus, and promoting granulation; can be used for treating short breath, palpitation, asthenia, collapse, spontaneous perspiration, night sweat, asthenia, edema, chronic nephritis, chronic diarrhea, proctoptosis, uterine prolapse, carbuncle, cellulitis, ulcer, infantile bronchial asthma, chronic hepatitis B, chronic nephritis, and viral myocarditis. Stir-baked for tonifying qi, unprocessed for checking sweating, inducing diuresis, expelling toxin, discharging pus and promoting tissue regeneration.
The invention has the following beneficial effects:
the traditional Chinese medicine composition has the advantages of simple raw materials, low cost, quick curative effect, simple and convenient use, improvement of the curative effect and no toxic or side effect by adopting a specific traditional Chinese medicine extraction method compared with other compositions for treating depression. Is suitable for patients with depression of different sexes and age groups, and is mainly used for treating mild and moderate depression and climacteric syndrome.
Detailed Description
The following further describes embodiments of the present invention with reference to examples. The following examples are only for illustrating the technical solutions of the present invention more clearly, and the protection scope of the present invention is not limited thereby.
Example 1
The traditional Chinese medicine formula for treating depression comprises the following components in parts by weight: 18 parts of tuckahoe, 14 parts of kudzu root, 8 parts of gastrodia elata, 10 parts of dogwood, 10 parts of angelica, 3 parts of ginseng, 8 parts of rhizoma polygonati, 8 parts of liquorice and 10 parts of astragalus membranaceus.
The traditional Chinese medicine needs 100 parts by weight of water, and is stewed in boiling water.
Boiling water was used for 3 hours under standard atmospheric pressure.
Example 2
The traditional Chinese medicine formula for treating depression comprises the following components in parts by weight: 20 parts of poria cocos, 15 parts of kudzu root, 9 parts of gastrodia elata, 11 parts of dogwood, 11 parts of angelica sinensis, 3 parts of ginseng, 9 parts of rhizoma polygonati, 9 parts of liquorice and 11 parts of astragalus membranaceus.
The traditional Chinese medicine needs 100 parts by weight of water, and is stewed in boiling water.
Boiling water was used for 3 hours under standard atmospheric pressure.
Example 3
The traditional Chinese medicine formula for treating depression comprises the following components in parts by weight: 22 parts of tuckahoe, 16 parts of kudzu root, 10 parts of rhizoma gastrodiae, 12 parts of dogwood, 12 parts of angelica, 4 parts of ginseng, 10 parts of rhizoma polygonati, 10 parts of liquorice and 12 parts of astragalus.
The traditional Chinese medicine is prepared by mixing 100 parts by weight of water, and stewing in boiling water.
Boiling water was used for 3 hours under standard atmospheric pressure.
The invention researches the medical records as follows: in the first case, a woman is 42 years old today, sleep disorder is about ten years old, the woman can sleep after lying for about two hours, the woman does not sleep all night seriously, the brain is uncontrolled, and the woman feels reluctant to think about, after eating 3 courses of traditional Chinese medicine this year, the sleep quality is improved greatly, the mind is joyful, and the body is relaxed.
Case two: zhao, a woman, 32 years old, 3 months postpartum, the self-describing emotion is extremely low, the feeling of anxiety, sitting and standing is uneasy, the mind is indefinite, the people love the spleen qi, the thinking is slow, the people feel tired, the people can hardly fall asleep without taking hypnotics at night, diagnosis and treatment are carried out before introduction by friends, the emotion and sleep are greatly improved after three months of treatment, and the people recover to be normal after half a year.
Case three, Dongqi, male, age 31. Disease occurred in 11 months in 2008, and 12 years so far. At that time, the patient can not feel suffocated and sleep at night, the illusion and the auditory hallucinations appear, western medicines such as viscusia, olanzapine and the like are taken, although the sleep is increased, the illusion always exists, the body is fat, and the emotion is dull. The traditional Chinese medicine formula is taken from No. 4/8, all the functions of the body are recovered, and the patient can not have trouble.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (6)
1. The traditional Chinese medicine formula for treating depression is characterized by comprising the following components in parts by weight: 18-22 parts of poria cocos, 14-16 parts of radix puerariae, 8-10 parts of rhizoma gastrodiae, 10-12 parts of dogwood, 10-12 parts of angelica sinensis, 3-4 parts of ginseng, 8-10 parts of rhizoma polygonati, 8-10 parts of liquorice and 10-12 parts of astragalus membranaceus.
2. The traditional Chinese medicine formula for treating depression according to claim 1, which is characterized by comprising the following components in parts by weight: 18 parts of tuckahoe, 14 parts of kudzu root, 8 parts of gastrodia elata, 10 parts of dogwood, 10 parts of angelica, 3 parts of ginseng, 8 parts of rhizoma polygonati, 8 parts of liquorice and 10 parts of astragalus membranaceus.
3. The traditional Chinese medicine formula for treating depression according to claim 1, which is characterized by comprising the following components in parts by weight: 20 parts of poria cocos, 15 parts of kudzu root, 9 parts of gastrodia elata, 11 parts of dogwood, 11 parts of angelica sinensis, 3 parts of ginseng, 9 parts of rhizoma polygonati, 9 parts of liquorice and 11 parts of astragalus membranaceus.
4. The traditional Chinese medicine formula for treating depression according to claim 1, which is characterized by comprising the following components in parts by weight: 22 parts of tuckahoe, 16 parts of kudzu root, 10 parts of rhizoma gastrodiae, 12 parts of dogwood, 12 parts of angelica, 4 parts of ginseng, 10 parts of rhizoma polygonati, 10 parts of liquorice and 12 parts of astragalus.
5. The traditional Chinese medicine formula for treating depression according to claim 1, wherein the traditional Chinese medicine is prepared by mixing 100 parts by weight of water and stewing in boiling water.
6. The traditional Chinese medicine formula for treating depression according to claim 5, wherein the boiling water stewing is carried out under a standard atmospheric pressure for 3 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210269117.4A CN114569677A (en) | 2022-03-18 | 2022-03-18 | Traditional Chinese medicine formula for treating depression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210269117.4A CN114569677A (en) | 2022-03-18 | 2022-03-18 | Traditional Chinese medicine formula for treating depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114569677A true CN114569677A (en) | 2022-06-03 |
Family
ID=81777140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210269117.4A Pending CN114569677A (en) | 2022-03-18 | 2022-03-18 | Traditional Chinese medicine formula for treating depression |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114569677A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450103A (en) * | 2007-11-30 | 2009-06-10 | 戚郁芬 | Medicine composition for treating hypochondria and anxiety neurosis |
| CN112826901A (en) * | 2019-11-24 | 2021-05-25 | 王忠民 | Medicine for quickly relieving senile dementia symptoms |
| CN113575944A (en) * | 2021-06-29 | 2021-11-02 | 任振芳 | Food additive with efficacy of expelling toxoplasma gondii and preparation method and application thereof |
-
2022
- 2022-03-18 CN CN202210269117.4A patent/CN114569677A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450103A (en) * | 2007-11-30 | 2009-06-10 | 戚郁芬 | Medicine composition for treating hypochondria and anxiety neurosis |
| CN112826901A (en) * | 2019-11-24 | 2021-05-25 | 王忠民 | Medicine for quickly relieving senile dementia symptoms |
| CN113575944A (en) * | 2021-06-29 | 2021-11-02 | 任振芳 | Food additive with efficacy of expelling toxoplasma gondii and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114306563B (en) | Gynecological climacteric menstruation moxibustion and preparation method thereof | |
| CN101129878A (en) | Traditional Chinese medicine preparation for treating uterine prolapse | |
| CN106581460A (en) | Intractable insomnia treatment medicine | |
| CN105031454A (en) | Medicine for treating pulmonary tuberculosis | |
| CN102145057A (en) | Antispasmodic traditional Chinese medicine composition and preparation method thereof | |
| CN103623280A (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases | |
| CN103638426B (en) | A kind for the treatment of is suffered from a deficiency of the kidney and the Traditional Chinese drug mixture of impotence and premature ejaculation | |
| CN109758561A (en) | It is a kind of for treating the Chinese materia medica preparation and preparation method thereof of obstinate type sleep disturbance | |
| CN105326993A (en) | Traditional Chinese medicine composition for treating spermatorrhea and premature ejaculation | |
| CN104257883A (en) | Traditional Chinese medicine composition for treating leucopenia after chemotherapy | |
| CN104225233A (en) | Orally-taken medicinal liquor capable of enriching yin and nourishing kidney | |
| CN103638234A (en) | Traditional Chinese medicine composition for treating tinnitus, preparation and preparation method thereof | |
| CN114569677A (en) | Traditional Chinese medicine formula for treating depression | |
| CN103223137B (en) | Traditional Chinese medicinal preparation for reducing blood sugar | |
| CN113575944A (en) | Food additive with efficacy of expelling toxoplasma gondii and preparation method and application thereof | |
| CN101904984A (en) | Traditional Chinese medicine for treating prolapse of anus | |
| CN112915148A (en) | A Chinese medicinal composition for treating sexual impotence, premature ejaculation and sexual disorder | |
| CN101229307B (en) | Rehabilitation oral Chinese traditional medicine preparation and preparing process thereof | |
| CN104857414A (en) | Medicine composite for treating chronic simple rhinitis | |
| CN1513509A (en) | Formula of chinese herbal medicine composition for whole life abstaining drug habit | |
| CN103340975A (en) | Traditional Chinese medicine for treating duodenal ulcer | |
| CN103751624B (en) | A kind of medicine and preparation method for the treatment of numb limbs and tense tendons after apoplexy | |
| CN103599397B (en) | A kind of Chinese medicine composition being used for the treatment of chronic renal insufficiency | |
| CN108355054A (en) | A kind of health-preserving medicinal liquor | |
| CN116173150A (en) | Traditional Chinese medicine preparation for treating anxiety and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20221118 Address after: 518000 Huafeng building, Xinzhou square, west side of Xinzhou overpass, Xinzhou Road, Futian District, Shenzhen, Guangdong 2001 Applicant after: Ren Zhenfang Applicant after: Xu Xianfeng Applicant after: Cui Cheng Address before: 518000 Huafeng building, Xinzhou square, west side of Xinzhou overpass, Xinzhou Road, Futian District, Shenzhen, Guangdong 2001 Applicant before: Shenzhen Zhongchang health Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220603 |
|
| RJ01 | Rejection of invention patent application after publication |